Quantification of Biomarker Functionality Predicts Patient Outcomes

Thumbnail
View/Open
Date
2021-05-11
Author
Larijani, Banafshé ORCID
Miles, James
Ward, Stephen G.
Parker, Peter J.
Metadata
Show full item record
  Estadisticas en RECOLECTA
(LA Referencia)

British Journal Of Cancer 124(10) : 1618-1620 (2021)
URI
http://hdl.handle.net/10810/51918
Abstract
Implementation of a quantitative molecular imaging method (iFRET), which determines receptor–ligand interactions, has led to the finding that patients with a low extent of PD-1/PD-L1 interaction in metastatic NSCLC, and malignant melanoma, display significantly worsened overall survival compared to those with a high level of interaction.
Collections
This article is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0)
Except where otherwise noted, this item's license is described as This article is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0)